Clinical Trial Update: Bacillus Calmette-Guerin (BCG) Vaccine and Morbidity From Malaria [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating whether the BCG vaccine affects malaria morbidity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Bacillus Calmette-Guerin (BCG) Vaccine (Bacillus Calmette-Guérin vaccine)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Malaria | Phase 3 | Status: COMPLETED